JPS63216486A - Production of mevalonic acid - Google Patents
Production of mevalonic acidInfo
- Publication number
- JPS63216486A JPS63216486A JP4962287A JP4962287A JPS63216486A JP S63216486 A JPS63216486 A JP S63216486A JP 4962287 A JP4962287 A JP 4962287A JP 4962287 A JP4962287 A JP 4962287A JP S63216486 A JPS63216486 A JP S63216486A
- Authority
- JP
- Japan
- Prior art keywords
- culture
- mevalonic acid
- genus
- carbon source
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KJTLQQUUPVSXIM-ZCFIWIBFSA-N (R)-mevalonic acid Chemical compound OCC[C@](O)(C)CC(O)=O KJTLQQUUPVSXIM-ZCFIWIBFSA-N 0.000 title claims abstract description 48
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 238000004519 manufacturing process Methods 0.000 title claims description 17
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 17
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 13
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000001301 oxygen Substances 0.000 claims abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 11
- 238000012258 culturing Methods 0.000 claims abstract description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 6
- 125000001477 organic nitrogen group Chemical group 0.000 claims abstract description 6
- 239000001888 Peptone Substances 0.000 claims abstract description 5
- 108010080698 Peptones Proteins 0.000 claims abstract description 5
- 229940041514 candida albicans extract Drugs 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 5
- 235000013372 meat Nutrition 0.000 claims abstract description 5
- 235000019319 peptone Nutrition 0.000 claims abstract description 5
- 239000012138 yeast extract Substances 0.000 claims abstract description 5
- 239000005018 casein Substances 0.000 claims abstract description 4
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000021240 caseins Nutrition 0.000 claims abstract description 4
- 235000013312 flour Nutrition 0.000 claims abstract description 3
- 241000235003 Saccharomycopsis Species 0.000 claims description 14
- 244000005700 microbiome Species 0.000 claims description 11
- 241000235648 Pichia Species 0.000 claims description 10
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 7
- 241000235070 Saccharomyces Species 0.000 claims description 7
- 241000221948 Sordaria Species 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 241000178951 Endomyces Species 0.000 claims description 3
- 241001149669 Hanseniaspora Species 0.000 claims 1
- 238000005273 aeration Methods 0.000 abstract description 5
- 239000002736 nonionic surfactant Substances 0.000 abstract description 3
- 244000068988 Glycine max Species 0.000 abstract description 2
- 235000010469 Glycine max Nutrition 0.000 abstract description 2
- 241000235004 Saccharomycopsis fibuligera Species 0.000 abstract description 2
- 238000013019 agitation Methods 0.000 abstract description 2
- 159000000007 calcium salts Chemical class 0.000 abstract description 2
- 159000000003 magnesium salts Chemical class 0.000 abstract description 2
- 150000003839 salts Chemical class 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract 2
- 230000000813 microbial effect Effects 0.000 abstract 2
- 150000003016 phosphoric acids Chemical class 0.000 abstract 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- 239000002609 medium Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000013028 medium composition Substances 0.000 description 3
- 238000010898 silica gel chromatography Methods 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 241001489166 Cyberlindnera fabianii Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- WJUFSDZVCOTFON-UHFFFAOYSA-N veratraldehyde Chemical compound COC1=CC=C(C=O)C=C1OC WJUFSDZVCOTFON-UHFFFAOYSA-N 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241001508787 Citeromyces Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 241000408710 Hansa Species 0.000 description 1
- 241001304302 Kuraishia capsulata Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 241000235059 Ogataea pini Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000521553 Pichia fermentans Species 0.000 description 1
- 241000521555 Pichia nakasei Species 0.000 description 1
- 235000005205 Pinus Nutrition 0.000 description 1
- 241000218602 Pinus <genus> Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 244000288561 Torulaspora delbrueckii Species 0.000 description 1
- 235000014681 Torulaspora delbrueckii Nutrition 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 150000002031 dolichols Chemical class 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 239000002952 polymeric resin Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000002728 pyrethroid Substances 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明はメバロン酸の製造方法、特に、メバロン酸を高
収率で得る方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a method for producing mevalonic acid, and particularly to a method for obtaining mevalonic acid in high yield.
尚、メバロン酸は酸型とラクトン型の2通りの構造を示
すが、相互に変換することが公知であり、以下本明細書
では特に断らない限り、両型を総称してメバロン酸とい
う。Note that mevalonic acid has two structures, an acid type and a lactone type, but it is known that they can be converted into each other, and hereinafter in this specification, unless otherwise specified, both types will be collectively referred to as mevalonic acid.
〔従来の技術及び発明が解決しようとする問題点メバロ
ン酸は、ライト等によって始めて単離された物質であり
(JAC3,78,5273,1956)コレステロー
ルを始めとする各種イソプレノイド化合物の重〕要な中
間体として知られている。[Problems to be solved by the prior art and the invention Mevalonic acid is a substance that was first isolated by Wright et al. Known as an intermediate.
又、メバロン酸は、種々の微生物及び植物に対して成育
促進作用を有する等、生物の代謝に重要な役割を果たし
ているため、微生物、植物等の成長促進剤として用いら
れ、また、ピレスロイド系農薬、ユビキノン(呼吸系補
酵素)、ドリコール(多**の生合成必須因子)、及び
脂溶性ビタミン等の前駆体等に用いられる。In addition, mevalonic acid plays an important role in the metabolism of living organisms, having a growth-promoting effect on various microorganisms and plants, and is therefore used as a growth promoter for microorganisms, plants, etc., and is also used as a pyrethroid pesticide. , ubiquinone (respiratory coenzyme), dolichol (multiple biosynthetic essential factors), and precursors of fat-soluble vitamins.
従来これらの研究には化学合成されたラセミ体が使用さ
れており、天然型のメバロン酸は入手し難いものであっ
た。Conventionally, these studies have used chemically synthesized racemates, and natural mevalonic acid has been difficult to obtain.
天然型のメバロン酸の醗酵法による製造は、アプライド
・マイクロバイオロジー(Applied Micr。The production of natural mevalonic acid by fermentation is carried out by Applied Microbiology (Applied Microbiology).
biology) 1旦、965 (1968)や米
国特許第3.617,447号明細書にサッカロマイコ
プシス・フィブリゲラ NRRL Y−9069を用
いた例が記載されているが、その収量は低く、700〜
1000μg/dにとどまり、工業的な生産には到って
いないのが現状である。Although examples using Saccharomycopsis fibrigera NRRL Y-9069 have been described in 965 (1968) and U.S. Patent No. 3,617,447, the yield is low and
At present, the amount is only 1000 μg/d, and industrial production has not yet been achieved.
従って、本発明の目的は、工業的に実施可能な程度に収
量の良いメバロン酸の製造方法を提供することにある。Therefore, an object of the present invention is to provide a method for producing mevalonic acid with a high yield that is industrially practicable.
本発明は、上記目的を、微生物を培地中で培養すること
によりメバロン酸を製造するに際し、窒素源としては有
機態窒素源のみを添加した培地を用いて培養し、次いで
該培養物からメバロン酸を得ることを特徴とするメバロ
ン酸の製造方法を提供することにより達成したものであ
る。The present invention aims to achieve the above-mentioned purpose by producing mevalonic acid by culturing microorganisms in a medium. This has been achieved by providing a method for producing mevalonic acid characterized by obtaining the following.
本発明に使用される好ましい微生物としては、例えばキ
ャンディダ(Candida) 属、ギリエモンデラ(
Gutlliers+ondella)属、ハンゼニア
スボラ(Ranseniaspora)属、ハンセヌラ
(Hansenula)属、ピキア(Pichta)属
、サッカロマイコプシス(Saccharo+wyco
psis)Eli−、サツカロミセス(Sacchar
omyces)属、シテロマイセス(CHeromyc
es)属、エンドマイコプシス(Endomycops
is)属、エンドマイセス(Endomyces)属
、ソルダリア(Sordaria)属からなる群から選
ばれる微生物が挙げられ、特にキャンディダ(Cand
ida) R、ハンセヌラ(Hansenula)属、
ピキア(Pichia)属、サッカロマイコプシス(S
accharomycopsis)属、サツカロミセス
(SaccharomyceS)属、エンドマイコプシ
ス(Endosycops is)属−エンドマイセス
(1!ndowyces)属の微生物を挙げることがで
き、具体的には、キャンディダ・シトレア(Candi
da cHrea) 、キャンディダ・フラギコラ(C
andida flagicola)、キャンディダ・
ラムビカ(Candida lambica)、キャン
ディダ・サケ(Candida 5ake)−、キャン
ディダ・スコチー(Candida 5cout) 、
Aンゼヌラ・ジメンネ(+Iansenuladl*5
nnae) 、ハンセヌラ・カリフォルニカ(Hans
enula carifornica) 、、 Aンゼ
ヌラ・ホルスチー(Hansenula holsti
i) 、ハンセヌラ・ヘンリシー(Hansenula
henriciL)、ハンセヌラ・ファビアニ−(H
ansenula fabianii)、ハンセヌラ・
メンタ(Ransenula m1nuta)、ハンセ
ヌラ・シルヴイコラ(Hansenula 5ilvi
cola) 、 ハンセヌラ・カプスラタ(Hansa
nula capsulata) 、ハンゼニアスポラ
・ペイジエリンキー01anseniaspora p
eijerinckii)、ピキア・ピヌス(Pich
ia pinus)、とキア・メムプラナエファシエン
ス(Plchia +*embranaefacien
s) sピキア・サイトイ(PichLa 5atto
i) 、サッカロマイコプシス・フィブリゲラ(Sac
charomycopsis fibuligera)
、サッカロマイコプシス・カブスラリス(Sacch
aromycopsis capsularis) s
サツカロミセス・ファーメンタティ(Saccharo
myces fermentati)、サツカロミセス
・デルプルエキ−(Saccharomyces de
lbrueckii) 、サツカロミセス・サイトアヌ
ス(Saccharomyces 5aitoanus
)−サツカロミセス・セレヴイシアエ(Sacchar
omyces cerevtsiae)、サツカロミセ
ス・ヴアフェル(Saccharomycesvafe
r)、エンドマイコプシス・フィブリゲラ(Endon
ycopsis fibuligera) 、エンドマ
イセス・フィブリゲラ(Endoa+yces fib
uligera)、ギリエモンデラ・セレノスポラ(G
uilliermondella 5elenospo
ra)、シテロマイセス・マトリテラシス(Citer
omyces matriteusis) 、ソルダリ
ア・フイミコラ(Sordarta ftm1cola
)等が例示出来、これらの肉量も好ましいのは、サッカ
ロマイコプシス・フィブリゲラ(Saccharomy
copsis fibultgera) であり〜これ
らに属する株としては、例えば、IFO0107、IF
O0103、IFO0104、TFO0105、IFO
0106、IFO0109、IFO0111、IFO1
665、IFO1711、IFO1744、IFO17
45、AHU 4113、IAM 4247、OU
T 6071、HUT 7234、ATCC208
0、ATCC2082、ATCC208B、ATCC9
947、ATCC20145、ATCC24945、A
TCC44872、ATCC46252、ATCC46
253、ATCC46949、ATCC52921、N
RRL Y−1060,NRRL Y−106
4、NRRL Y−2385、NRRLY−’70
61、NRRL Y−7221、NRRL Y
−7324、NRRL Y−7464、NRRL
Y−9069、DSM 70554、 IAM
4025、 IFO1342、IFOO800、
IFo 1880.IFo 0980、IFO
1477、IFO1254、TFOO975、IFO0
807、IFO0984、IAM 4945、IF
o 185(1、[AM4307、 rFo
0672、 IAM 4771、IAM 12
236、 IAM 12241、 IFo 1
002、 IFO1003、IFO1626、IFO1
572、IFO1574、IFo 1146、 I
FO1213、IFO1287、IFO0954、IF
O0941、rFo 8812を挙げることが出来る
。Preferred microorganisms used in the present invention include, for example, Candida genus, Guillemondella (
Gutlliers+ondella), Ranseniaspora, Hansenula, Pichta, Saccharomycopsis
psi) Eli-, Saccharomyces
omyces), genus Cheromyces
es), Endomycops
Examples include microorganisms selected from the group consisting of the genus Is), the genus Endomyces, and the genus Sordaria, particularly Candida.
ida) R, Hansenula spp.
Pichia genus, Saccharomycopsis (S
Examples include microorganisms of the genera Saccharomycopsis, Saccharomyces, and Endosycops-1!ndowyces, and specifically, Candida citrea.
da cHrea), Candida fragicola (C
andida flagicola), candida flagicola
Candida lambica, Candida 5ake, Candida 5cout,
Anzenula Jimenne (+Iansenuladl*5
nnae), Hanssenula californica (Hans
enula carifornica),, A Hansenula holsti (Hansenula holsti)
i) , Hansenula henrisii
henriciL), Hansenula fabianii (H
ansenula fabianii), Hansenula fabianii)
Ransenula m1nuta, Hansenula 5ilvi
cola), Hansenula capsulata (Hansa)
nula capsulata), Anseniaspora p.
eijerinckii), Pichia pinus (Pich
ia pinus), and Plchia ++embranaefacien
s) PichLa 5atto
i), Saccharomycopsis fibrigera (Sac
charomycopsis fibuligera)
, Saccharomycopsis cabuslaris (Saccharomycopsis cabuslaris)
allomycopsis capsularis)
Saccharomyces fermentati
myces fermentati), Saccharomyces de
lbrueckii), Saccharomyces 5aitoanus
) - Saccharomyces cerevisiae (Sacchar
omyces cerevtsiae), Saccharomyces vafe
r), Endomycopsis fibrigera (Endon
ycopsis fibuligera), Endomyces fibuligera (Endoa+yces fib
uligera), Guilliemondella selenospora (G.
uillier mondella 5elenospo
ra), Citelomyces matritellasis (Citer
omyces matriteusis), Sordaria fuimicola (Sordaria ftm1cola)
), and the preferable meat amount is Saccharomycopsis fibrigera (Saccharomycopsis fibrigera).
Copsis fibultgera) ~ Strains belonging to these include, for example, IFO0107, IF
O0103, IFO0104, TFO0105, IFO
0106, IFO0109, IFO0111, IFO1
665, IFO1711, IFO1744, IFO17
45, AHU 4113, IAM 4247, OU
T6071, HUT7234, ATCC208
0, ATCC2082, ATCC208B, ATCC9
947, ATCC20145, ATCC24945, A
TCC44872, ATCC46252, ATCC46
253, ATCC46949, ATCC52921, N
RRL Y-1060,NRRL Y-106
4, NRRL Y-2385, NRRLY-'70
61, NRRL Y-7221, NRRL Y
-7324, NRRL Y-7464, NRRL
Y-9069, DSM 70554, IAM
4025, IFO1342, IFOO800,
IFo 1880. IFo 0980, IFO
1477, IFO1254, TFOO975, IFO0
807, IFO0984, IAM 4945, IF
o 185(1, [AM4307, rFo
0672, IAM 4771, IAM 12
236, IAM 12241, IFo 1
002, IFO1003, IFO1626, IFO1
572, IFO1574, IFo1146, I
FO1213, IFO1287, IFO0954, IF
O0941 and rFo8812 can be mentioned.
尚、IFO,ATCC,NRRL、DSM、AHU、I
AM、OUT、HUTはそれぞれ財団法人醗酵研究所保
存菌株、アメリカンタイプ・カルチャー・コレクション
保存苗株、ARSノーザンレジョナル・リサーチセンタ
ー保存菌株、トイチェ・ザンムルング・フォノ・ミクロ
オルガニズメン保存菌株、北海道大学農学部保存菌株、
東京大学応用微生物研究所保存菌株、大阪大学工学部醗
酵工学科保存菌株、広島大学工学部醗酵工学科保存菌株
を示す。In addition, IFO, ATCC, NRRL, DSM, AHU, I
AM, OUT, and HUT are the strains preserved by the Fermentation Research Institute, the American Type Culture Collection, the ARS Northern Regional Research Center, the Teutje Sammlung Fono Microorganismen, and the Faculty of Agriculture, Hokkaido University. preserved strains,
Shown are strains preserved at the Institute of Applied Microbiology, the University of Tokyo, strains preserved at the Department of Fermentation Engineering, Faculty of Engineering, Osaka University, and strains preserved at the Department of Fermentation Engineering, Faculty of Engineering, Hiroshima University.
本発明で使用する培地組成としては、窒素源としては有
機態窒素源のみ、例えばペプトン、イーストエキストラ
クト、ミートエキストラクト、カゼイン、大豆粉等を使
用し、無機窒素源を添加しない限り通常使用される培地
を使用することができ、具体的な培地組成の例としては
、例えば炭素源5〜15重量%、有機態窒素源0.5〜
3重量%及び水(残部)からなる培地を挙げることがで
き、更に燐酸塩、カリウム塩、マグネシウム塩、カルシ
ウム塩等の無機塩類を各々0.01〜5重量%含むもの
も挙げることができる。Regarding the medium composition used in the present invention, only organic nitrogen sources such as peptone, yeast extract, meat extract, casein, soybean flour, etc. are used as the nitrogen source, and unless an inorganic nitrogen source is added, ordinary nitrogen sources are used. A specific medium composition includes, for example, a carbon source of 5 to 15% by weight and an organic nitrogen source of 0.5 to 15% by weight.
Examples include a medium containing 3% by weight and water (the balance), and also a medium containing 0.01 to 5% by weight each of inorganic salts such as phosphates, potassium salts, magnesium salts, and calcium salts.
尚、培地中に非イオン界面活性剤0.02〜0.1重量
%を含有させると、メバロン酸の取得量が増加するので
好ましい、。Note that it is preferable to include 0.02 to 0.1% by weight of a nonionic surfactant in the medium, since this increases the amount of mevalonic acid obtained.
また、本発明のメバロン酸の製造方法においては、培養
中の培養物における培養液(培養物の濾液)の炭素源濃
度を2〜15重量%、好ましくは5〜10重量%に維持
すると、メバロン酸の取得量を増加させることができる
ので好ましい。In addition, in the method for producing mevalonic acid of the present invention, if the carbon source concentration of the culture solution (culture filtrate) in the culture being cultivated is maintained at 2 to 15% by weight, preferably 5 to 10% by weight, mevalonate This is preferable because the amount of acid obtained can be increased.
炭素源濃度を上記範囲に維持する方法としては、少なく
とも炭素源を含む基質を培養中の培養物に添加する方法
を挙げることができる。A method for maintaining the carbon source concentration within the above range includes a method of adding a substrate containing at least a carbon source to the culture during cultivation.
上記基質の添加を行う場合には、培養物における培養液
(培養物の濾液)中の炭素源濃度が上記範囲に維持され
るように培養物に流加するのが良い、しかしながら、−
aに炭素源濃度の測定には長時間を要するので基質添加
時期の判断は培養物のpH又は溶存酸素量を指標とする
のが良い。When adding the above-mentioned substrate, it is preferable to add it to the culture so that the carbon source concentration in the culture solution (culture filtrate) is maintained within the above-mentioned range. However, -
Since it takes a long time to measure the carbon source concentration in (a), it is best to use the pH of the culture or the amount of dissolved oxygen as an indicator for determining the timing of substrate addition.
pHを指標とする場合にはpHが7以上となる点が、ま
た、溶存酸素量を指標とする場合には溶存酸素量が一旦
低下し、再度上昇し始めた時点、即ち溶存酸素量の曲線
の(飽和を初期値とする)掻小値の通過直後が指標とな
る。When pH is used as an indicator, the point at which the pH becomes 7 or higher is used as an indicator, and when the amount of dissolved oxygen is used as an indicator, the point when the amount of dissolved oxygen decreases once and starts to rise again, that is, the curve of dissolved oxygen amount. The point immediately after passing the minimum value (with saturation as the initial value) becomes the index.
尚、この時添加する基質の量は、予め、指標の時点にお
ける炭素源濃度を測定しておき、それに応じた量を流加
すればよい。The amount of substrate to be added at this time may be determined by measuring the carbon source concentration at the time of the index in advance, and adding an amount corresponding to that.
添加する基質は、少なくとも炭素源を含むものであれば
良く、培養前の培地組成と同一でも異なっていても良い
が、好ましい炭素源としては、例えば、グルコース、フ
ラクトース、マルトース、マルトエキス、グリセリン、
酢酸塩等が挙げられる。また、添加する時の基質の形態
は、無菌状態であれば制限されないが、殺菌の容易性等
から水溶液として用いるのが好ましく、その場合の濃度
も制限されないが、高濃度(例えば、40%以上)とす
るのが好ましい。The substrate to be added may be one containing at least a carbon source, and may be the same or different from the medium composition before culturing, but preferred carbon sources include, for example, glucose, fructose, maltose, malto extract, glycerin,
Examples include acetate. Further, the form of the substrate when added is not limited as long as it is sterile, but it is preferable to use it as an aqueous solution from the viewpoint of ease of sterilization, etc. In that case, the concentration is also not limited, but it should be at a high concentration (for example, 40% or more). ) is preferable.
本発明の製造方法の好ましい具体的実施態様は以下の通
りである。Preferred specific embodiments of the manufacturing method of the present invention are as follows.
即ち、炭素源、有m態窒素源、細胞膜の可溶化作用を持
つ非イオン界面活性剤及び無機塩類を所定量含有する培
地に微生物を接種し、20〜40℃、好ましくは25〜
35℃で震盪培養するか、100〜500 r pm、
好ましくは200〜400rpm、0.2〜1.5VV
M、好ましくは0.5〜1、OVVMで通気攪拌培養し
、所定時間培養した後、培養物における培養液中の炭素
源濃度の測定、pl(の測定、又は溶存酸素量の測定に
より、前記基質を培養物に流加(添加)する、このよう
な基質の流加を必要回数行い、それ以上メバロン酸の生
産量が向上しないと判断した時点で培養を終了する。培
養終了後、培養物を遠心分離、濾過等公知の方法で菌体
を除き、逆浸透法、減圧1留等により濃縮するか、ブタ
ノールや酢酸エチルを用いた向流分配法或いはシリカゲ
ル、ダイヤイオン、イオン交換樹脂等を使用したカラム
クロマトグラフィ法、分子蒸留法、結晶化法等の公知の
精製技術の組合せにより処理してメバロン酸を得ること
ができる。That is, a microorganism is inoculated into a medium containing a carbon source, a meta-nitrogen source, a nonionic surfactant with a cell membrane solubilizing effect, and an inorganic salt in a predetermined amount, and the microorganism is heated at 20-40°C, preferably at 25-40°C.
Incubate with shaking at 35°C or 100-500 rpm,
Preferably 200-400 rpm, 0.2-1.5VV
M, preferably 0.5 to 1, aerated agitation culture with OVVM, and after culturing for a predetermined period of time, the above-mentioned The substrate is fed (added) to the culture, and the substrate is fed as many times as necessary, and the culture is terminated when it is judged that the production amount of mevalonic acid does not increase any further.After the culture is finished, the culture is Remove bacterial cells using known methods such as centrifugation and filtration, and concentrate using reverse osmosis, vacuum distillation, etc., countercurrent distribution method using butanol or ethyl acetate, or silica gel, diamond ion, ion exchange resin, etc. Mevalonic acid can be obtained by a combination of known purification techniques such as column chromatography, molecular distillation, and crystallization.
尚、本発明の方法における培地には、本発明の目的の範
囲内で、所望により消泡剤等を添加することができる。It should be noted that an antifoaming agent or the like may be added to the culture medium in the method of the present invention, if desired, within the scope of the purpose of the present invention.
また、培養液中の炭素源濃度の測定は、グルコースオキ
シダーゼを用いる酵素法等により行い、この場合の「培
養液」とは、培養物を遠心分離、濾過等により国体等を
除いた溶液部をいう。In addition, the carbon source concentration in the culture solution is measured by an enzymatic method using glucose oxidase, etc. In this case, the "culture solution" refers to the solution portion of the culture from which Kokutai, etc. are removed by centrifugation, filtration, etc. say.
以下に本発明の実施例を示すが、本発明はこれらに限定
されるものではない。Examples of the present invention are shown below, but the present invention is not limited thereto.
尚、実施例、比較例におけるメバロン酸の定量は以下の
ようにして行った。In addition, the quantitative determination of mevalonic acid in Examples and Comparative Examples was performed as follows.
試料溶液0.8−をスビッチ管に取り、I N−HCJ
溶液を用いてpHを2に調整する。これにNazsOa
lgを加え、更に酢酸エチル2.0 mを加えて攪拌後
、上層を取る。下層に更に酢酸エチル2.0 mを加え
て攪拌後、上層を取り前回の上層と合わせる。再度この
操作を行い、酢酸エチル層計6.0 mを得、これを蒸
発乾固する。この乾固物を3.4−ジメトキシベンズア
ルデヒドを内部標準としてガスクロマトグラフィにより
定量した。Take 0.8- of the sample solution in a subic tube and
Adjust the pH to 2 using the solution. NazsOa for this
After adding 2.0 m of ethyl acetate and stirring, remove the upper layer. Add 2.0 m of ethyl acetate to the lower layer and stir, then remove the upper layer and combine with the previous upper layer. Repeat this operation to obtain a total of 6.0 m of ethyl acetate layer, which is evaporated to dryness. This dried product was quantified by gas chromatography using 3,4-dimethoxybenzaldehyde as an internal standard.
尚、ガスクロマトグラフィの条件は以下の通り。The conditions for gas chromatography are as follows.
カラムサイズ:直径31n長さ10100Oステンレス
製)
カラム液相:10%Thermon−3000カラムサ
ポート:chromosorb WAW−0MC38
0〜100メツ
シユ
カラム温度:180℃
インジェクション温度:230℃
キャリアーガスjNt (40m/分)〔実施例1、
比較例1〕
グルコース10重量%、マルトエキストラクト1重量%
、ペプトン0.5重量%、イーストエキストラクト0.
1重量%、KHz PO40,3重量%、Mg 304
・7 Hz 00.05重量%、(:、aCOs1重
量%、残部水からなる培地201と200−を用意し、
該200−の培地にサッカロマイコプシス・フィブリゲ
ラIFO1744を1白金耳接種し28℃で3日間震盪
壇養しておいたものを、上記2(lの培地に接種し、2
8℃、回転数30Qrpm、通気量2(H!/分で通気
攪拌培養した。Column size: diameter 31n length 10100O made of stainless steel) Column liquid phase: 10% Thermon-3000 Column support: chromosorb WAW-0MC38
0-100 mesh column temperature: 180°C Injection temperature: 230°C Carrier gas jNt (40m/min) [Example 1,
Comparative Example 1] Glucose 10% by weight, malt extract 1% by weight
, peptone 0.5% by weight, yeast extract 0.
1% by weight, KHz PO40, 3% by weight, Mg 304
・Prepare media 201 and 200- consisting of 7 Hz 00.05% by weight, (:, aCOs 1% by weight, and the balance water,
One platinum loop of Saccharomycopsis fibrigera IFO 1744 was inoculated into the 200-liter medium and incubated at 28°C for 3 days with shaking.
Culture was carried out with aeration at 8° C., rotation speed 30 Qrpm, and aeration rate 2 (H!/min).
6日間培養をw1続して得られたメバロン酸の量は11
60μg/−であった。The amount of mevalonic acid obtained after culturing for 6 days was 11
It was 60 μg/−.
また、上記培地に更に塩化アンモニウムを0.3重量%
添加して培養した場合(比較例1)は6日間培養してメ
バロン酸の量は910gg/dであった。In addition, 0.3% by weight of ammonium chloride was added to the above medium.
When cultured with the addition of mevalonic acid (Comparative Example 1), the amount of mevalonic acid was 910 gg/d after 6 days of culture.
〔実施例2〕
実施例1と同様の培地を、28℃、回転数309rpm
、通気12017分でグルコース濃度、pH,溶存酸素
量を測定しつつ通気攪拌培養した。[Example 2] The same culture medium as in Example 1 was grown at 28°C and at a rotation speed of 309 rpm.
After 12017 minutes of aeration, the culture was carried out with aeration while measuring the glucose concentration, pH, and amount of dissolved oxygen.
培養3日目に培養液中のグルコース量を測定してグルコ
ース濃度が5%以下になったことを確認した後、この時
点でグルコースの50重量%水溶液を2.0 kg流加
し、培養を1!続した。更に、培養6日目及び培養9日
目にそれぞれグルコースの50重置%水溶液を2.0
kirを流加し、計12日間培養を継続し培養を終了し
た。培養終了後、培養物から得たメバロン酸を、前記定
量法により測定したところ、メバロン酸の量は201Q
11g/−であった。After measuring the amount of glucose in the culture solution on the third day of culture and confirming that the glucose concentration was 5% or less, at this point, 2.0 kg of a 50% by weight aqueous solution of glucose was added and the culture was continued. 1! continued. Furthermore, on the 6th day of culture and the 9th day of culture, a 50% aqueous solution of glucose was added at 2.0%.
Kir was fed to the cells, and the culture was continued for a total of 12 days, and then the culture was completed. After the cultivation was completed, mevalonic acid obtained from the culture was measured using the quantitative method described above, and the amount of mevalonic acid was 201Q.
It was 11g/-.
第1図は、本実施例における培養時間と、溶存酸素m
(*和−100とする)、pHbグルコース量(重量%
)、及びメバロン酸量(重量%)それぞれとの関係を示
すグラフで、このグラフから、培養3日目に培養液中の
グルコース濃度が5%以下となった直後にpHが7を越
え、溶存酸素量は掻小値を通過している事がわかる。Figure 1 shows the culture time and dissolved oxygen m in this example.
(* Sum - 100), pHb glucose amount (wt%
), and the amount of mevalonic acid (wt%). From this graph, it can be seen that immediately after the glucose concentration in the culture solution became 5% or less on the third day of culture, the pH exceeded 7, and dissolved It can be seen that the amount of oxygen has passed through the minimum value.
〔実施例3〕
イーストエキストラクトをミートエキストラクトに替え
たほかは実施例2と同様にして培養した。[Example 3] Culture was carried out in the same manner as in Example 2 except that yeast extract was replaced with meat extract.
その結果得られたメバロン酸の量は2070μg/dで
あった。The amount of mevalonic acid obtained as a result was 2070 μg/d.
〔実施例4〕
ペプトンをカゼインに替えたほかは実施例2と同様にし
て培養した。その結果得られたメバロン酸の量は197
0μg/dであった。[Example 4] Culture was carried out in the same manner as in Example 2 except that peptone was replaced with casein. The amount of mevalonic acid obtained as a result was 197
It was 0 μg/d.
〔実施例5〕
サッカロマイコプシス・フィブリゲラIFO1744を
サッカロマイコプシス・フィブリゲラIFO0107に
替えたほかは実施例2と同様に培養した。その結果得ら
れたメバロン酸の量は8590μg/dであった。[Example 5] Culture was carried out in the same manner as in Example 2 except that Saccharomycopsis fibrigera IFO1744 was replaced with Saccharomycopsis fibrigera IFO0107. The amount of mevalonic acid obtained as a result was 8590 μg/d.
〔実施例6〕
実施例2で得た培養物22I2を回転数500Orpm
で遠心分離し濾液141を得た。これを逆浸i31*を
用いて41に濃縮後50重量%リン酸水を用いてpH2
とし、41の酢酸エチルで3回抽出し、酢酸エチル層1
21を得た。これを0.02N水酸化ナトリウム水51
に転溶し、50重量%リン酸水にてpH2とした後、ダ
イヤイオン1(P−20カラム(11)を通した。この
流出液を、41の酢酸エチルで3回抽出し、酢酸エチル
層121を得た。これを無水硫酸ナトリウムにて脱水後
蒸発乾固させた。この乾固物を少量のアセトン/ベンゼ
ン(1/7)に溶解させ、シリカゲルカラムクロマトグ
ラフィー(150g)により分離した。メバロン酸を含
む画分を乾固し、無色の油状物質14.4 gを得た。[Example 6] The culture 22I2 obtained in Example 2 was rotated at a rotation speed of 500 rpm.
The mixture was centrifuged to obtain filtrate 141. This was concentrated to 41 using reverse immersion i31*, and then adjusted to pH 2 using 50% by weight phosphoric acid water.
41 and extracted three times with ethyl acetate, and the ethyl acetate layer 1
I got 21. Add this to 51 liters of 0.02N sodium hydroxide solution.
After adjusting the pH to 2 with 50% by weight phosphoric acid water, it was passed through a Diaion 1 (P-20 column (11)).The effluent was extracted three times with ethyl acetate in 41, Layer 121 was obtained. This was dehydrated with anhydrous sodium sulfate and then evaporated to dryness. This dried product was dissolved in a small amount of acetone/benzene (1/7) and separated by silica gel column chromatography (150 g). The fraction containing mevalonic acid was dried to obtain 14.4 g of a colorless oily substance.
比旋光度(α) I’−−21,6゜ (C−2,31、エタノール)であった。Specific optical rotation (α) I’--21,6° (C-2,31, ethanol).
本発明のメバロン酸の製造方法によれば、工業的に実施
可能な程度に高収量でメバロン酸を得ることができる。According to the method for producing mevalonic acid of the present invention, mevalonic acid can be obtained in an industrially high yield.
第1図は、本発明の実施例1における培養時間と、溶存
酸素量(taiO−100とす4) 、pH、グルコー
ス量(重量%)、及びメバロン酸量(重量%)それぞれ
との関係を表すグラフであり、図中、1はメバロン酸量
、2はグルコース量、3はpH,4は溶存酸素量をそれ
ぞれ示す。
培 養 日 fll(日)
手続補正書
昭和62年 4月 6日
メバロン酸の製法
7、?!正の内容
(1)第3頁11行のr (JAC3,78,5273
,1956)Jを「(ジャーナル・オプ・ジ・アメリカ
ン・ケミカル・ソサイエティ(Journal of
the AmericanChe+wical 5oc
iety) 78巻、5273〜5275頁、1956
年)」と補正。
(2)第12頁15行の「ダイヤイオン」を「ポーラス
ポリマー樹脂」と補正。
(3)第17頁12行〜13行の「ダイヤイオンHP−
204を「ダイヤイオンHP−20(登録商標)」と補
正。
(4)第17頁17行〜18行の「シリカゲルカラムク
ロマトグラフィー(150g)Jを「シリカゲルカラム
クロマトグラフィー(ワコーゲルC−200(登録商標
)、1500g)Jと補正。
+51第181(10行〜11行の「メバロン酸量(重
量%)」を「メバロン酸量(μg/sl) Jと社正。
以」Figure 1 shows the relationship between the culture time and the amount of dissolved oxygen (taiO-100 and 4), pH, amount of glucose (wt%), and amount of mevalonic acid (wt%) in Example 1 of the present invention. In the figure, 1 indicates the amount of mevalonic acid, 2 indicates the amount of glucose, 3 indicates the pH, and 4 indicates the amount of dissolved oxygen. Cultivation date fll (Sunday) Procedural amendment April 6, 1988 Manufacturing method of mevalonic acid 7, ? ! Correct content (1) r on page 3, line 11 (JAC3, 78, 5273
, 1956) J. (Journal of the American Chemical Society)
the AmericanChe+wical 5oc
iety) Vol. 78, pp. 5273-5275, 1956
2013)”. (2) "Diaion" on page 12, line 15 was corrected to "porous polymer resin." (3) “Diaion HP-” on page 17, lines 12-13
204 was corrected to "Diaion HP-20 (registered trademark)". (4) Correct “Silica gel column chromatography (150g) J” on page 17, lines 17 to 18 to “Silica gel column chromatography (Wakogel C-200 (registered trademark), 1500g) J. +51 No. 181 (line 10 to "Amount of mevalonic acid (wt%)" in line 11 is changed to "Amount of mevalonic acid (μg/sl) J and Masaaki."
Claims (7)
を製造するに際し、窒素源として有機態窒素源のみを添
加した培地を用いて培養し、次いで該培養物からメバロ
ン酸を得ることを特徴とするメバロン酸の製法。(1) When producing mevalonic acid by culturing microorganisms in a medium, the culture is performed using a medium to which only an organic nitrogen source is added as a nitrogen source, and then mevalonic acid is obtained from the culture. A method for producing mevalonic acid.
トラクト、ミートエキストラクト、カゼイン大豆粉から
なる群から選ばれた1種または2種以上の物質を使用す
ることを特徴とする特許請求の範囲第(1)項記載のメ
バロン酸の製法。(2) As an organic nitrogen source, one or more substances selected from the group consisting of peptone, yeast extract, meat extract, and casein soy flour are used. The method for producing mevalonic acid described in (1).
添加して培養することを特徴とする特許請求の範囲第(
1)項の何れかに記載のメバロン酸の製法。(3) The culture is carried out by adding a substrate containing at least a carbon source to the culture.
1) The method for producing mevalonic acid according to any one of items 1).
5重量%に維持されるように基質の添加を行うことを特
徴とする特許請求の範囲第(3)項記載のメバロン酸の
製法。(4) Carbon source concentration in the culture solution (culture filtrate) is 2 to 1
The method for producing mevalonic acid according to claim (3), characterized in that the substrate is added so that the concentration is maintained at 5% by weight.
で行うことを特徴とする特許請求の範囲第(3)項に記
載のメバロン酸の製法。(5) The method for producing mevalonic acid according to claim (3), characterized in that the substrate is added when the pH of the culture reaches 7 or higher.
培養日数)の変曲点を通過した時点で行うことを特徴と
する特許請求の範囲第(3)項に記載のメバロン酸の製
法。(6) Mevalonic acid according to claim (3), characterized in that the addition of the substrate is carried out at the time when the curve indicating the amount of dissolved oxygen in the culture (versus the number of days of culture) has passed an inflection point. manufacturing method.
属、ギリエモンデラ(Guilliermondell
a)属、ハンゼニアスポラ(Hanseniaspor
a)属、ハンゼヌラ(Hansenula)属、ピキア
(Pichia)属、サッカロマイコプシス(Sacc
haromycopsis)属、サッカロミセス(Sa
ccharomyces)属、シテロマイセス(Cit
eromyces)属、エンドマイコプシス(Endo
mycopsis)属、エンドマイセス(Endomy
ces)属、ソルダリア(Sordaria)属からな
る群から選ばれる微生物を使用することを特徴とする特
許請求の範囲第(1)項の何れかに記載のメバロン酸の
製法。(7) Candida as a microorganism
Genus, Guilliermondella
a) Genus Hanseniaspora
a) Genus Hansenula, Genus Pichia, Genus Saccharomycopsis (Sacc)
genus haromycopsis, Saccharomyces (Sa
genus ccharomyces, genus Citellomyces
eromyces), Endomycopsis (Endo mycopsis)
genus mycopsis, Endomyces
The method for producing mevalonic acid according to claim 1, characterized in that a microorganism selected from the group consisting of the genus Ces and Sordaria is used.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4962287A JPH0789940B2 (en) | 1987-03-04 | 1987-03-04 | Manufacturing method of mevalonic acid |
AT88103319T ATE86664T1 (en) | 1987-03-04 | 1988-03-03 | PROCESS FOR THE PRODUCTION OF MEVALONIC ACID. |
ES88103319T ES2053596T3 (en) | 1987-03-04 | 1988-03-03 | A PROCESS FOR THE PRODUCTION OF MEVALONIC ACID. |
DE8888103319T DE3878946T2 (en) | 1987-03-04 | 1988-03-03 | METHOD FOR PRODUCING MEVALONIC ACID. |
EP88103319A EP0281143B1 (en) | 1987-03-04 | 1988-03-03 | Process for producing mevalonic acid |
US07/629,184 US5149641A (en) | 1987-03-04 | 1990-12-17 | Process for producing mevalonic acid |
GR930400328T GR3007316T3 (en) | 1987-03-04 | 1993-03-11 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4962287A JPH0789940B2 (en) | 1987-03-04 | 1987-03-04 | Manufacturing method of mevalonic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63216486A true JPS63216486A (en) | 1988-09-08 |
JPH0789940B2 JPH0789940B2 (en) | 1995-10-04 |
Family
ID=12836330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4962287A Expired - Lifetime JPH0789940B2 (en) | 1987-03-04 | 1987-03-04 | Manufacturing method of mevalonic acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0789940B2 (en) |
-
1987
- 1987-03-04 JP JP4962287A patent/JPH0789940B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH0789940B2 (en) | 1995-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0148132B1 (en) | Microbiological process for stereoselectively synthesizing l(-)-carnitine | |
JPH02150287A (en) | Method of fermentation | |
US4535059A (en) | Muconic acid productivity by a stabilized mutant microorganism population | |
US4657863A (en) | Stabilization of a mutant microorganism population | |
Boeck et al. | NEW AZASTEROIDAL ANTIFUNGAL ANTIBIOTICS FROM GEOTRICHU FLAVO-BRUNNEUM I. DISCOVERY AND FERMENTATION STUDIES | |
US4595659A (en) | Fermentation production of ascorbic acid from L-galactonic substrate | |
JP2792600B2 (en) | Mevalonic acid producing bacteria | |
EP0344163A1 (en) | Process for the preparation of xylitol from xylose by cultivating candida guilliermondii | |
JPS63216486A (en) | Production of mevalonic acid | |
JPH03155792A (en) | 5-decanoride and its preparation | |
JPS63216484A (en) | Production of mevalonic acid | |
US4916068A (en) | Bioconversion production of ascorbic acid with L-galactono-1,4-oxidase | |
JPS63216487A (en) | Production of mevalonic acid | |
US3725200A (en) | Process for fermentative production of yeast cells | |
KR900005771B1 (en) | Process for the preparation of glutamic acid | |
JPS63216485A (en) | Production of mevalonic acid | |
JP2845385B2 (en) | Novel mutant strain and method for producing glycerin using the same | |
JPH02291293A (en) | Production of ethyl-alpha-glucoside | |
JPS63283588A (en) | Production of carboxylic acid by microbiological fermentation of alcohol | |
HU204575B (en) | Process for producing 1-methyl-1,4-androstadiene-3,17-dion | |
Tauro et al. | L-Lysine production by Uestilaginales fungi | |
US3121668A (en) | Method for the production of 1-glutamic acid | |
JPS5857156B2 (en) | Production method of coenzyme Q↓1↓0 by fermentation method | |
JPS6125490A (en) | Preparation of coenzyme q10 | |
JPS5921600B2 (en) | Method for producing D(-)-β-hydroxyisobutyric acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |